Chargement en cours...
Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
Telbivudine was recently approved for the treatment of chronic hepatitis B. Phase III studies indicated its antiviral potency with 6- to 6.5-log copies/mL reductions in hepatitis B DNA levels at year 1, comparable to other potent agents such as entecavir or tenofovir. Genotypic resistance rates, how...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2762437/ https://ncbi.nlm.nih.gov/pubmed/19851526 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|